Cargando…

Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt

BACKGROUND: Venous thromboembolism (VTE) is a leading cause of hospital-related deaths worldwide. However, the proportion of patients at risk of VTE who receive appropriate prophylaxis in Egypt is unknown. The ENDORSE study in Egypt is part of a global initiative to uncover the incidence of high-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Goubran, Hadi A, Sholkamy, Sherif, El-Haddad, Alaa, Mahmoud, Alaa, Rizkallah, Mounir A, Sobhy, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502290/
https://www.ncbi.nlm.nih.gov/pubmed/22950681
http://dx.doi.org/10.1186/1477-9560-10-20
_version_ 1782250305944027136
author Goubran, Hadi A
Sholkamy, Sherif
El-Haddad, Alaa
Mahmoud, Alaa
Rizkallah, Mounir A
Sobhy, George
author_facet Goubran, Hadi A
Sholkamy, Sherif
El-Haddad, Alaa
Mahmoud, Alaa
Rizkallah, Mounir A
Sobhy, George
author_sort Goubran, Hadi A
collection PubMed
description BACKGROUND: Venous thromboembolism (VTE) is a leading cause of hospital-related deaths worldwide. However, the proportion of patients at risk of VTE who receive appropriate prophylaxis in Egypt is unknown. The ENDORSE study in Egypt is part of a global initiative to uncover the incidence of high-risk surgical and medical patients and determine what proportion of these patients receive appropriate VTE prophylaxis. METHODS: Ten Egyptian hospitals participated in this observational study, enrolling all surgical and medical patients that met the study criteria. This resulted in a cohort of 1,008 patients in acute care facilities who underwent a retrospective chart review. Each patient’s VTE risk status and the presence or absence of appropriate prophylactic care was assessed according to the American College of Chest Physicians (ACCP) guidelines 2004. RESULTS: Of the 1,008 patients enrolled, 395 (39.2%) were found to be at high-risk for VTE. Overall, 227 surgical patients were at high-risk, although only 80 (35.2%) received ACCP-recommended prophylaxis. Similarly, 55/268 (32.75%) of high-risk medical patients received appropriate VTE prophylaxis. Low molecular weight heparin was the most commonly used anticoagulant, while mechanical prophylactic use was quite low (1.5%) in high-risk patients. CONCLUSIONS: In Egypt, more than one-third of all patients hospitalized for surgery or acute medical conditions are at high risk for developing VTE. However, only a small fraction of these patients receive appropriate VTE prophylaxis. Corrective measures are necessary for preventing VTE morbidity and mortality in these high risk patients.
format Online
Article
Text
id pubmed-3502290
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35022902012-11-21 Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt Goubran, Hadi A Sholkamy, Sherif El-Haddad, Alaa Mahmoud, Alaa Rizkallah, Mounir A Sobhy, George Thromb J Original Clinical Investigation BACKGROUND: Venous thromboembolism (VTE) is a leading cause of hospital-related deaths worldwide. However, the proportion of patients at risk of VTE who receive appropriate prophylaxis in Egypt is unknown. The ENDORSE study in Egypt is part of a global initiative to uncover the incidence of high-risk surgical and medical patients and determine what proportion of these patients receive appropriate VTE prophylaxis. METHODS: Ten Egyptian hospitals participated in this observational study, enrolling all surgical and medical patients that met the study criteria. This resulted in a cohort of 1,008 patients in acute care facilities who underwent a retrospective chart review. Each patient’s VTE risk status and the presence or absence of appropriate prophylactic care was assessed according to the American College of Chest Physicians (ACCP) guidelines 2004. RESULTS: Of the 1,008 patients enrolled, 395 (39.2%) were found to be at high-risk for VTE. Overall, 227 surgical patients were at high-risk, although only 80 (35.2%) received ACCP-recommended prophylaxis. Similarly, 55/268 (32.75%) of high-risk medical patients received appropriate VTE prophylaxis. Low molecular weight heparin was the most commonly used anticoagulant, while mechanical prophylactic use was quite low (1.5%) in high-risk patients. CONCLUSIONS: In Egypt, more than one-third of all patients hospitalized for surgery or acute medical conditions are at high risk for developing VTE. However, only a small fraction of these patients receive appropriate VTE prophylaxis. Corrective measures are necessary for preventing VTE morbidity and mortality in these high risk patients. BioMed Central 2012-09-05 /pmc/articles/PMC3502290/ /pubmed/22950681 http://dx.doi.org/10.1186/1477-9560-10-20 Text en Copyright ©2012 Goubran et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Clinical Investigation
Goubran, Hadi A
Sholkamy, Sherif
El-Haddad, Alaa
Mahmoud, Alaa
Rizkallah, Mounir A
Sobhy, George
Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
title Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
title_full Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
title_fullStr Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
title_full_unstemmed Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
title_short Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt
title_sort venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the endorse study in egypt
topic Original Clinical Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502290/
https://www.ncbi.nlm.nih.gov/pubmed/22950681
http://dx.doi.org/10.1186/1477-9560-10-20
work_keys_str_mv AT goubranhadia venousthromboembolismriskandprophylaxisintheacutehospitalcaresettingreportfromtheendorsestudyinegypt
AT sholkamysherif venousthromboembolismriskandprophylaxisintheacutehospitalcaresettingreportfromtheendorsestudyinegypt
AT elhaddadalaa venousthromboembolismriskandprophylaxisintheacutehospitalcaresettingreportfromtheendorsestudyinegypt
AT mahmoudalaa venousthromboembolismriskandprophylaxisintheacutehospitalcaresettingreportfromtheendorsestudyinegypt
AT rizkallahmounira venousthromboembolismriskandprophylaxisintheacutehospitalcaresettingreportfromtheendorsestudyinegypt
AT sobhygeorge venousthromboembolismriskandprophylaxisintheacutehospitalcaresettingreportfromtheendorsestudyinegypt